Advance Search
CHEN Lu, XU Lei. Research progress on correlation between muscular calf vein thrombosis and pulmonary embolism[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 141-148. DOI: 10.7619/jcmp.20223749
Citation: CHEN Lu, XU Lei. Research progress on correlation between muscular calf vein thrombosis and pulmonary embolism[J]. Journal of Clinical Medicine in Practice, 2023, 27(12): 141-148. DOI: 10.7619/jcmp.20223749
shu

Research progress on correlation between muscular calf vein thrombosis and pulmonary embolism

  • Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010050

More Information
  • Received Date: December 14, 2022
  • Revised Date: March 06, 2023
  • Available Online: July 07, 2023
    Graphical Abstract
    • Abstract

  • Muscular calf vein thrombosis (MCVT) is the common site of deep vein thrombosis (DVT) in the lower extremities. Researchers have found that MCVT can progress to the proximal deep vein and cause more severe DVT in lower limbs, or thrombus detachment can lead to secondary pulmonary thromboembolism (PTE) and even sudden death. This paper mainly explored the incidence of MCVT complicated with PTE, the possible anatomical factors related to MCVT and PTE, the influencing factors of MCVT complicated with PTE, and the current status of risk assessment of PTE in MCVT patients, in order to provide reference for early identification of high risk of PTE and guidance for personalized clinical decision-making in MCVT patients.

    • FullText(HTML)
    • References (83)
  • [1]
    ESSIEN E O, RALI P, MATHAI S C. Pulmonary embolism[J]. Med Clin North Am, 2019, 103(3): 549-564. doi: 10.1016/j.mcna.2018.12.013
    [2]
    EXPERT PANEL ON VASCULAR IMAGING, BENNETT S J, DILL K E, et al. ACR appropriateness criteria® suspected thoracic aortic aneurysm[J]. J Am Coll Radiol, 2018, 15(5S): S208-S214.
    [3]
    ZHAO W G, YAN J Y, LI X L, et al. Characteristics and treatment strategy of isolated calf deep venous thrombosis after fractures: a review of recent literature[J]. Orthop Surg, 2022, 14(7): 1263-1270. doi: 10.1111/os.13292
    [4]
    MACDONALD P S, KAHN S R, MILLER N, et al. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis[J]. J Vasc Surg, 2003, 37(3): 523-527. doi: 10.1067/mva.2003.149
    [5]
    唐兴华. 小腿肌间静脉血栓与肺栓塞发生相关性及小腿肌间静脉血栓形成危险因素的研究[D]. 济南: 山东大学, 2017.
    [6]
    LAUTZ T B, ABBAS F, WALSH S J, et al. Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation[J]. Ann Surg, 2010, 251(4): 735-742. doi: 10.1097/SLA.0b013e3181c1ae95
    [7]
    余宇潇. 小腿肌间静脉血栓预后的临床研究[D]. 贵州: 遵义医科大学, 2019.
    [8]
    QIU T, ZHANG T, LIU L, et al. The anatomic distribution and pulmonary embolism complications of hospital-acquired lower extremity deep venous thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2021, 9(6): 1391-1398. doi: 10.1016/j.jvsv.2021.03.004
    [9]
    EL-MENYAR A, ASIM M, JABBOUR G, et al. Clinical implications of the anatomical variation of deep venous thrombosis[J]. Phlebology, 2018, 33(2): 97-106. doi: 10.1177/0268355516687863
    [10]
    吴义娟. 不同部位下肢深静脉血栓的危险因素及其发生肺栓塞的相关性分析[D]. 大连: 大连医科大学, 2021.
    [11]
    GILLET J L, PERRIN M R, ALLAERT F A. Short-term and mid-term outcome of isolated symptomatic muscular calf vein thrombosis[J]. J Vasc Surg, 2007, 46(3): 513-519. doi: 10.1016/j.jvs.2007.04.040
    [12]
    谢俊. 小腿肌间静脉血栓进展为肺栓塞的危险因素及治疗[D]. 大理: 大理大学, 2021.
    [13]
    KRET M R, LIEM T K, MITCHELL E L, et al. Isolated calf muscular vein thrombosis is associated with pulmonary embolism and a high incidence of additional ipsilateral and contralateral deep venous thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2013, 1(1): 33-38. doi: 10.1016/j.jvsv.2012.04.001
    [14]
    司云鹏. 膝上与膝下深静脉血栓与肺栓塞相关性研究[D]. 山东: 山东第一医科大学, 2019.
    [15]
    HUGHES M J, STEIN P D, MATTA F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review[J]. Thromb Res, 2014, 134(6): 1182-1185. doi: 10.1016/j.thromres.2014.09.036
    [16]
    WEI M, ZHU J, YI X, et al. The prevalence of isolated calf deep vein thrombosis in patients with pulmonary embolism[J]. Int Angiol, 2013, 32(5): 465-470.
    [17]
    崔风强, 袁时芳, 王占奎, 等. 不同类型肺栓塞发病原因的临床分析[J]. 血管与腔内血管外科杂志, 2021, 7(4): 426-429. doi: 10.19418/j.cnki.issn2096-0646.2021.04.11
    [18]
    罗燕华. 64例肺栓塞的下肢深静脉及心脏超声分析[J]. 现代医用影像学, 2020, 29(10): 1869-1871. doi: 10.3969/j.issn.1006-7035.2020.10.023
    [19]
    ZHANG P, BIAN Y, XU F, et al. The incidence and characteristics of venous thromboembolism in neurocritical care patients: a prospective observational study[J]. Clin Appl Thromb Hemost, 2020, 26: 1076029620907954.
    [20]
    郭莉莉, 赵凯军, 郑美娜. 肺栓塞合并下肢深静脉血栓78例分析[J]. 中国实验诊断学, 2013, 17(2): 273-274. doi: 10.3969/j.issn.1007-4287.2013.02.021
    [21]
    OHGI S, TACHIBANA M, IKEBUCHI M, et al. Pulmonary embolism in patients with isolated soleal vein thrombosis[J]. Angiology, 1998, 49(9): 759-764.
    [22]
    HOLLERWEGER A, MACHEINER P, RETTENBACHER T, et al. Sonographic diagnosis of thrombosis of the calf muscle veins and the risk of pulmonary embolism[J]. Ultraschall Med, 2000, 21(2): 66-72. doi: 10.1055/s-2000-8929
    [23]
    VAN LANGEVELDE K, SRÁMEK A, VINCKEN P W, et al. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique[J]. Haematologica, 2013, 98(2): 309-315. doi: 10.3324/haematol.2012.069195
    [24]
    孙树东. 不同部位下肢深静脉血栓与急性肺栓塞后肺动脉高压严重程度的相关性研究[D]. 承德: 承德医学院, 2021.
    [25]
    刘奇志, 吴卫华, 陈洁, 等. 超声下不同部位下肢静脉血栓与肺栓塞发生的相关性分析[J]. 中国临床医学, 2020, 27(4): 620-623. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202004019.htm
    [26]
    PHAM X B D, DE VIRGILIO C. Significance of isolated calf vein thrombosis-further evidence[J]. JAMA Surg, 2016, 151(9): e161799. doi: 10.1001/jamasurg.2016.1799
    [27]
    KUCZMIK W, WYSOKINSKI W E, HESLEY G K, et al. Calf vein thrombosis comparison of outcomes for axial and muscular venous thrombosis[J]. Thromb Haemost, 2021, 121(2): 216-223. doi: 10.1055/s-0040-1715646
    [28]
    YAMAKI T, HAMAHATA A, SOEJIMA K, et al. Factors predicting development of post-thrombotic syndrome in patients with a first episode of deep vein thrombosis: preliminary report[J]. Eur J Vasc Endovasc Surg, 2011, 41(1): 126-133. doi: 10.1016/j.ejvs.2010.09.018
    [29]
    GALANAUD J P, SEVESTRE-PIETRI M A, BOSSON J L, et al. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study[J]. Thromb Haemost, 2009, 102(3): 493-500.
    [30]
    RO A, KAGEYAMA N, MUKAI T. Pathophysiology of venous thromboembolism with respect to the anatomical features of the deep veins of lower limbs: a review[J]. Ann Vasc Dis, 2017, 10(2): 99-106. doi: 10.3400/avd.ra.17-00035
    [31]
    COTTON L T, CLARK C. Anatomical localization of venous thrombosis[J]. Ann R Coll Surg Engl, 1965, 36(4): 214-224.
    [32]
    GALANAUD J P, SEVESTRE M A, GENTY C, et al. Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis[J]. J Vasc Surg, 2010, 52(4): 932-938, 938. doi: 10.1016/j.jvs.2010.05.019
    [33]
    XIAO S Q, GENG X, ZHAO J L, et al. Risk factors for potential pulmonary embolism in the patients with deep venous thrombosis: a retrospective study[J]. Eur J Trauma Emerg Surg, 2020, 46(2): 419-424. doi: 10.1007/s00068-018-1039-z
    [34]
    LUO X L, ZHANG L Y, HOU C C, et al. Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?[J]. Thromb J, 2022, 20(1): 52. doi: 10.1186/s12959-022-00410-1
    [35]
    YOON D Y, RIAZ A, TETER K, et al. Surveillance, anticoagulation, or filter in calf vein thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(1): 25-32. doi: 10.1016/j.jvsv.2016.08.007
    [36]
    GARRY J, DUKE A, LABROPOULOS N. Systematic review of the complications following isolated calf deep vein thrombosis[J]. Br J Surg, 2016, 103(7): 789-796. doi: 10.1002/bjs.10152
    [37]
    SCHWARZ T, SCHMIDT B, BEYER J, et al. Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin[J]. Blood Coagul Fibrinolysis, 2001, 12(7): 597-599. doi: 10.1097/00001721-200110000-00014
    [38]
    SCHWARZ T, BUSCHMANN L, BEYER J, et al. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study[J]. J Vasc Surg, 2010, 52(5): 1246-1250. doi: 10.1016/j.jvs.2010.05.094
    [39]
    STEVENS S M, WOLLER S C, KREUZIGER L B, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report[J]. Chest, 2021, 160(6): e545-e608. doi: 10.1016/j.chest.2021.07.055
    [40]
    RIGHINI M, GALANAUD J P, GUENNEGUEZ H, et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial[J]. Lancet Haematol, 2016, 3(12): e556-e562. doi: 10.1016/S2352-3026(16)30131-4
    [41]
    SALES C M, HAQ F, BUSTAMI R, et al. Management of isolated soleal and gastrocnemius vein thrombosis[J]. J Vasc Surg, 2010, 52(5): 1251-1254. doi: 10.1016/j.jvs.2010.05.102
    [42]
    XIA Z N, XIAO K, ZHU W, et al. Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture[J]. J Orthop Surg Res, 2018, 13(1): 291. doi: 10.1186/s13018-018-0998-4
    [43]
    KAKKOS S K, GOHEL M, BAEKGAARD N, et al. Editor's choice-European society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis[J]. Eur J Vasc Endovasc Surg, 2021, 61(1): 9-82. doi: 10.1016/j.ejvs.2020.09.023
    [44]
    MAZZOLAI L, AGENO W, ALATRI A, et al. Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function[J]. Eur J Prev Cardiol, 2022, 29(8): 1248-1263. doi: 10.1093/eurjpc/zwab088
    [45]
    WEI, FENG. RANKL-independent modulation of osteoclastogenesis[J]. J Oral Biosci, 2019, 61(1): 16-21. doi: 10.1016/j.job.2019.01.001
    [46]
    TRAN H A, GIBBS H, MERRIMAN E, et al. New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism[J]. Med J Aust, 2019, 210(5): 227-235. doi: 10.5694/mja2.50004
    [47]
    ROBERT-EBADI H, RIGHINI M. Management of distal deep vein thrombosis[J]. Thromb Res, 2017, 149: 48-55. doi: 10.1016/j.thromres.2016.11.009
    [48]
    NARAYAN A, ENG J, CARMI L, et al. Iliac vein compression as risk factor for left- versus right-sided deep venous thrombosis: case-control study[J]. Radiology, 2012, 265(3): 949-957. doi: 10.1148/radiol.12111580
    [49]
    MEBAZAA A, SPIRO T E, BVLLER H R, et al. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure[J]. Circulation, 2014, 130(5): 410-418. doi: 10.1161/CIRCULATIONAHA.113.003126
    [50]
    ZHANG C W, LI Q, YU H, et al. Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2020, 8(5): 725-733. doi: 10.1016/j.jvsv.2019.11.010
    [51]
    GONG S M, LEE E J, KIM J S, et al. Association between laterality and location of deep vein thrombosis of lower extremity and pulmonary embolism[J]. Vasc Specialist Int, 2021, 37: 12. doi: 10.5758/vsi.200075
    [52]
    BIKDELI B, SHARIF-KASHANI B, BIKDELI B, et al. Impact of Thrombus sidedness on presentation and outcomes of patients with proximal lower extremity deep vein thrombosis[J]. Semin Thromb Hemost, 2018, 44(4): 341-347. doi: 10.1055/s-0037-1621716
    [53]
    袁晓庆, 苏晓雪, 杜刘念博, 等. 急性下肢深静脉血栓形成部位与发生肺栓塞的关系分析[J]. 血管与腔内血管外科杂志, 2022, 8(5): 542-548. https://www.cnki.com.cn/Article/CJFDTOTAL-XGQW202205007.htm
    [54]
    SEINTURIER C, BOSSON J L, COLONNA M, et al. Site and clinical outcome of deep vein thrombosis of the lower limbs: an epidemiological study[J]. J Thromb Haemost, 2005, 3(7): 1362-1367. doi: 10.1111/j.1538-7836.2005.01393.x
    [55]
    庞晶, 杨远舰, 杨梦, 等. 小腿肌间静脉血栓合并肺栓塞的危险因素[J]. 河南医学研究, 2018, 27(14): 2509-2511. doi: 10.3969/j.issn.1004-437X.2018.14.005
    [56]
    GUIAS B, SIMONI G, OGER E, et al. Calf muscle venous thrombosis and pulmonary embolism[J]. J Mal Vasc, 1999, 24(2): 132-134.
    [57]
    凌端强. 小腿肌间静脉血栓合并肺栓塞的临床研究[D]. 太原: 山西医科大学, 2016.
    [58]
    陈央, 周海霞, 胡月红, 等. 老年和非老年肺栓塞的危险因素及Caprini血栓风险评估量表的预测价值[J]. 中华医学杂志, 2017, 97(10): 755-760. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ201712040.htm
    [59]
    张毅, 赵卉, 刘云峰, 等. 下肢深静脉血栓形成后发生肺栓塞的危险因素分析[J]. 临床肺科杂志, 2019, 24(5): 790-793. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK201905004.htm
    [60]
    王昊辰, 崔紫阳, 李丽蕊, 等. 肺栓塞合并下肢深静脉血栓危险因素分析[J]. 华北理工大学学报: 医学版, 2018, 20(5): 384-389. https://www.cnki.com.cn/Article/CJFDTOTAL-MTYX201805009.htm
    [61]
    杨德华, 于龙飞, 张健, 等. 恶性肿瘤与非恶性肿瘤合并下肢深静脉血栓患者肺栓塞发生率的比较[J]. 中国普通外科杂志, 2012, 21(12): 1497-1499. doi: 10.7659/j.issn.1005-6947.2012.12.004
    [62]
    张春燕. 老年深静脉血栓形成患者发生肺栓塞危险因素分析[J]. 中国病案, 2016, 17(5): 84-86. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGBN201605034.htm
    [63]
    刘祝. 深静脉血栓形成合并肺栓塞患者危险因素分析[D]. 天津: 天津医科大学, 2020.
    [64]
    董祥利. 由下肢深静脉血栓引发肺栓塞的因果分析[J]. 双足与保健, 2019, 28(7): 64-65. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBJ201907032.htm
    [65]
    刘向东, 赵家宁, 吴文娟, 等. 下肢外伤后小腿深静脉血栓脱落四例[J]. 中华普通外科杂志, 2014, 29(8): 641-642. doi: 10.3760/cma.j.issn.1007-631X.2014.08.024
    [66]
    CHEN X Y, LIU X, LIU J L, et al. Pulmonary embolism secondary to deep venous thrombosis: a retrospective and observational study for clinical characteristics and risk stratification[J]. Phlebology, 2021, 36(8): 627-635. doi: 10.1177/0268355521990964
    [67]
    HOU J X, WANG W Y, CAI H, et al. Patients with right lower extremity deep vein thrombosis have a higher risk of symptomatic pulmonary embolism: a retrospective study of 1585 patients[J]. Ann Vasc Surg, 2022, 81: 240-248. doi: 10.1016/j.avsg.2021.08.049
    [68]
    SINGH K, YAKOUB D, GIANGOLA P, et al. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis[J]. J Vasc Surg, 2012, 55(1): 136-140. doi: 10.1016/j.jvs.2011.07.088
    [69]
    BRATEANU A, PATEL K, CHAGIN K, et al. Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis[J]. Thromb Haemost, 2016, 115(3): 608-614. doi: 10.1160/th15-06-0503
    [70]
    SARTORI M, MIGLIACCIO L, FAVARETTO E, et al. Two years outcome of isolated distal deep vein thrombosis[J]. Thromb Res, 2014, 134(1): 36-40. doi: 10.1016/j.thromres.2014.03.033
    [71]
    BERNARDI E, CAMPORESE G, BVLLER H R, et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial[J]. JAMA, 2008, 300(14): 1653-1659. doi: 10.1001/jama.300.14.1653
    [72]
    AISSAOUI N, MARTINS E, MOULY S, et al. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both[J]. Int J Cardiol, 2009, 137(1): 37-41. doi: 10.1016/j.ijcard.2008.06.020
    [73]
    GRUETTNER J, VIERGUTZ T, BOLTE M, et al. Importance of risk factors for the evaluation of patients with a suspected pulmonary embolism[J]. Exp Ther Med, 2015, 9(6): 2281-2284. doi: 10.3892/etm.2015.2395
    [74]
    KABASHNEH S, SINGH V, ALKASSIS S. A comprehensive literature review on the management of distal deep vein thrombosis[J]. Cureus, 2020, 12(5): e8048.
    [75]
    陈东海, 陈鑫遥, 蔡彦, 等. 肺栓塞合并下肢深静脉血栓患者的临床特征分析[J]. 临床急诊杂志, 2022, 23(5): 305-309. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202205002.htm
    [76]
    LI H L, CHAN Y C, LI N, et al. Prevalence and predictor of pulmonary embolism in a cohort of Chinese patients with acute proximal deep vein thrombosis[J]. Ann Vasc Surg, 2020, 63: 293-297. doi: 10.1016/j.avsg.2019.06.042
    [77]
    高玉海, 高群, 魏强, 等. 下肢深静脉血栓并发肺栓塞的临床特征及危险因素分析[J]. 浙江中西医结合杂志, 2021, 31(3): 273-276. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZH202103024.htm
    [78]
    EKICI M, EKICI A, ĪLERI Ş. Chronic CT features in PE patients with co-existing DVT[J]. Am J Emerg Med, 2021, 46: 126-131.
    [79]
    韦永涵, 廖新红, 高泳, 等. 彩色多普勒超声检查联合D-二聚体及C反应蛋白检测对下肢深静脉血栓合并肺血栓的预测价值[J]. 右江民族医学院学报, 2017, 39(6): 458-461, 468. https://www.cnki.com.cn/Article/CJFDTOTAL-YJMZ201706010.htm
    [80]
    孟燕, 田红燕, 马强, 等. C反应蛋白在肺栓塞患者中的临床价值[J]. 中华全科医学, 2012, 10(3): 349-350. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201203010.htm
    [81]
    田锦林, 王海峰, 屈尔青, 等. Wells、修正后的Geneva评分与肺栓塞严重程度指数对下肢深静脉血栓患者发生肺栓塞的预测价值[J]. 临床荟萃, 2015, 30(3): 297-300. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFC201503016.htm
    [82]
    WONG D D, RAMASESHAN G, MENDELSON R M. Comparison of the Wells and Revised Geneva Scores for the diagnosis of pulmonary embolism: an Australian experience[J]. Intern Med J, 2011, 41(3): 258-263.
    [83]
    郗萌, 罗丹, 周蓉, 等. 下肢静脉血栓患者Wells评分及相关危险因素分析[J]. 中国医药, 2020, 15(7): 1058-1062. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202007021.htm
    • Related Articles

  • Cited by

    Periodical cited type(38)

    1. 张丽芳. 雌二醇屈螺酮片治疗更年期综合征的临床效果及对患者内分泌和免疫功能的影响. 中国妇幼保健. 2022(03): 558-560 .
    2. 周春，赵丽兰，韦凤仙. 阿戈美拉汀联合雌激素与阿戈美拉汀单药治疗围绝经期抑郁症的效果. 心理月刊. 2022(11): 40-42+48 .
    3. 潘琳. 低剂量雌激素替代疗法治疗围绝经期综合征的临床效果. 临床合理用药杂志. 2022(26): 99-101 .
    4. 王若茜，刘莹，刘永奇. 绝经前子宫切除术后出现围绝经期症状患者激素替代治疗效果. 中国计划生育学杂志. 2021(02): 262-265 .
    5. 刘艳，李荣梅，童赟. 雌孕激素治疗围绝经期综合征对改善神经递质水平及不良情绪疗效. 中国计划生育学杂志. 2021(03): 482-484 .
    6. 龚美富，胡樱. 围绝经期综合征患者中医证候分布及发病影响因素分析. 中国妇幼保健. 2021(11): 2645-2648 .
    7. 吴明媛. 不同剂量雌激素联合黄体酮治疗围绝经期综合征的疗效分析. 实用中西医结合临床. 2021(12): 122-123 .
    8. 李海超. 产妇产后首发急性精神障碍的影响因素分析. 中国妇幼保健. 2021(13): 3050-3053 .
    9. 周益平，廖文莲，汪昆华. 针灸调体联合雌孕激素治疗阴虚内热型围绝经期综合征临床观察. 基层医学论坛. 2021(35): 5092-5094 .
    10. 刘燕，张静. 戊酸雌二醇片对围绝经期综合征患者更年期综合征评分、雌激素水平与不良反应的影响. 实用临床医药杂志. 2020(01): 109-111 . 本站查看
    11. 张慧君，沈志娟，覃小敏，李琳，周敏，徐敏，何敏，张伟，王丽，郭红，张燕. 低剂量结合雌激素与标准剂量CEE联合天然黄体酮或地屈孕酮对围绝经期综合征患者骨密度的影响研究. 中国骨质疏松杂志. 2020(02): 198-201 .
    12. 闫学花，陈建军，闫利荣，杨泉林，刘向娇，苏心镜. 穴位电刺激联合耳穴贴压对围绝经期综合征患者焦虑抑郁症状、生活质量及神经递质的影响. 河北医药. 2020(04): 562-564+568 .
    13. 钟吉芳，赖贵维. 丹红注射液结合性激素替代疗法治疗围绝经期心律失常的临床价值. 中国妇幼保健. 2020(08): 1458-1460 .
    14. 闫学花，杨玲，刘向娇，闫利荣，苏心镜. 穴位电刺激联合耳穴贴压对围绝经期综合征患者免疫炎性反应和氧化应激的影响. 河北医药. 2020(07): 1044-1046+1050 .
    15. 崔娟. 用低剂量的雌激素替代疗法对围绝经期综合征患者进行治疗的效果研究. 当代医药论丛. 2020(06): 61-63 .
    16. 史馨莹，张明，徐静瑶. 苁蓉菟丝子丸联合戊酸雌二醇治疗更年期综合征临床研究. 新中医. 2020(10): 90-92 .
    17. 罗媛华. 低剂量雌激素替代疗法在围绝经期综合征患者中的疗效及对患者激素水平变化的影响. 中国处方药. 2020(05): 51-52 .
    18. 刘群香，李瑞青，叶海丽. 小剂量雌孕激素替代治疗对围绝经期综合征患者性激素水平的影响. 中国妇幼保健. 2020(11): 2047-2050 .
    19. 苏芳芳，许张晔. 局部用药结合激素替代疗法对围绝经期女性激素水平和阴道炎症的临床效果研究. 中国妇幼保健. 2020(12): 2278-2280 .
    20. 胡萌萌，蔡慧慧，卜德云，张小佳. 女性围绝经期综合征相关影响因素及健康管理干预效果分析. 中国医学创新. 2020(16): 26-30 .
    21. 胡艳萍，李馨. 坤泰胶囊联合雌二醇片/雌二醇地屈孕酮片复合包装治疗围绝经期综合征患者效果观察及对性激素、抗缪勒管激素和骨密度的影响. 中国医师进修杂志. 2020(04): 346-347-348-349 .
    22. 党宁，王云燕. 激素替代疗法对围绝经期综合征患者症状及免疫功能的影响. 河南医学研究. 2020(28): 5290-5292 .
    23. 张伟峰，何普红，杨丽萍. 不同激素替代治疗对围绝经期综合征患者的疗效观察. 临床医学. 2020(11): 116-118 .
    24. 任国丽，邓春霞，张凡，高立亚，孙鸿博，赵桂君. 不同剂量结合雌激素联合地屈孕酮治疗围绝经期综合征效果. 中国计划生育学杂志. 2020(12): 1983-1986 .
    25. 李益书，马春季. 新加龙牡汤联合激素替代疗法治疗围绝经期综合征临床研究. 四川中医. 2020(12): 179-182 .
    26. 张德源，谭家蓉，向燕卿. 帕罗西汀联合心理治疗对女性围绝经期情绪障碍、睡眠质量及血清性激素水平的影响. 解放军医药杂志. 2019(01): 74-78 .
    27. 柳树萍. 激素替代治疗对围绝经期综合征患者子宫内膜厚度和激素水平的影响. 医疗装备. 2019(02): 15-16 .
    28. 尧艳俊. 低剂量雌激素替代疗法对围绝经期综合征患者血清性激素水平的影响. 临床医学. 2019(06): 87-89 .
    29. 陈金环. 小剂量雌、孕激素替代疗法治疗围绝经期综合征的效果探讨. 实用妇科内分泌电子杂志. 2019(19): 59+68 .
    30. 舒俊俊，龚丹，晏三华，范博群. 小剂量戊酸雌二醇片对围绝经期综合征患者激素水平及骨密度的影响. 当代医学. 2019(33): 153-155 .
    31. 李慧，牛彩霞. 低剂量雌激素替代治疗围绝经期综合征的临床疗效及其对患者激素水平和生活质量的影响. 临床合理用药杂志. 2018(03): 54-55 .
    32. 魏林. 中西医结合治疗更年期综合征临床分析. 中外医学研究. 2018(20): 6-8 .
    33. 吕琦. 激素替代治疗对围绝经期综合征妇女子宫内膜厚度和激素水平的影响分析. 医学信息. 2018(05): 133-135 .
    34. 马美婧. 浅谈激素替代治疗对围绝经期综合症的改善. 世界最新医学信息文摘. 2018(91): 109 .
    35. 林丹燕. 低剂量雌激素替代疗法对围绝经期症状及激素水平的影响价值分析. 中国医药科学. 2018(24): 101-103+163 .
    36. 宋雨菊，桑锋. 更年滋肾汤合玉女酥对雌性去势大鼠下丘脑-垂体-性腺轴的影响. 中外医疗. 2017(21): 5-8 .
    37. 于德双. 低剂量雌激素替代疗法对围绝经期症状及激素水平的影响. 世界最新医学信息文摘. 2017(77): 93-94 .
    38. 李丹妍. 激素替代治疗对围绝经期综合征妇女子宫内膜厚度和激素水平的影响分析. 中国医学创新. 2017(22): 32-35 .

    Other cited types(7)

Catalog

    Get Citation
    PDF
    XML
    Article views (248) PDF downloads (56) Cited by(45)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return